Mitochondrial quality control in neurodegenerative diseases

Biochimie

Volumn 100, Issue 1, 2014, Pages 177-183

  Dupuis, Luc ^a,b  

^a Laboratoire des Mecanismes Centraux et Peripheriques de la Neurodegenerescence   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Amyotrophic lateral; Charcot Marie Tooth disease; Mitophagy; Parkinson's disease; Sclerosis

Indexed keywords

CELL FUNCTION; DEGENERATIVE DISEASE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; GENE REPRESSION; HUMAN; MITOCHONDRIAL DYNAMICS; NONHUMAN; PHYSIOLOGY; QUALITY CONTROL; REVIEW;

AMYOTROPHIC LATERAL; CHARCOT-MARIE-TOOTH DISEASE; MITOPHAGY; PARKINSON'S DISEASE; SCLEROSIS;

AUTOPHAGY; DYNEINS; GENE EXPRESSION REGULATION; GTP PHOSPHOHYDROLASES; HUMANS; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; MUTATION; NEURODEGENERATIVE DISEASES; NEURONS; PROTEIN KINASES; SIGNAL TRANSDUCTION; UBIQUITIN-PROTEIN LIGASES;

EID: 84897048042     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2013.07.033     Document Type: Review

References (100)

1. L.J. Martin, Biology of mitochondria in neurodegenerative diseases, Prog. Mol. Biol. Transl. Sci. 107 (2012) 355-415.
2. M. Cozzolino, A. Ferri, C. Valle, M.T. Carri, Mitochondria and ALS: implications from novel genes and pathways, Mol. Cell Neurosci. 55 (2013) 44-49.
3. M. Cozzolino, M.T. Carri, Mitochondrial dysfunction in ALS, Prog. Neurobiol. 97 (2012) 54-66.
4. N. Exner, A.K. Lutz, C. Haass, K.F. Winklhofer, Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences, EMBO J. 31 (2012) 3038-3062.
5. A. Pilsl, K.F. Winklhofer, Parkin, PINK1 and mitochondrial integrity: emerging concepts of mitochondrial dysfunction in Parkinson's disease, Acta Neuropathol. 123 (2012) 173-188.
6. R.K. Chaturvedi, M.F. Beal, Mitochondria targeted therapeutic approaches in Parkinson's and Huntington's diseases, Mol. Cell Neurosci. 55 (2013) 101-114.
7. D.N. Hauser, T.G. Hastings, Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism, Neurobiol. Dis. 51 (2013) 35-42.
8. F. Mochel, R.G. Haller, Energy deficit in Huntington disease: why it matters, J. Clin. Invest. 121 (2011) 493-499.
9. V. Costa, L. Scorrano, Shaping the role of mitochondria in the pathogenesis of Huntington's disease, EMBO J. 31 (2012) 1853-1864.
10. D.F. Silva, J.E. Selfridge, J. Lu, L. E, S.M. Cardoso, R.H. Swerdlow, Mitochondrial abnormalities in Alzheimer's disease: possible targets for therapeutic intervention, Adv. Pharmacol. 64 (2012) 83-126.
11. D.C. Chan, Fusion and fission: interlinked processes critical for mitochondrial health, Annu. Rev. Genet. 46 (2012) 265-287.
12. G. Twig, A. Elorza, A.J. Molina, H. Mohamed, J.D. Wikstrom, G. Walzer, L. Stiles, S.E. Haigh, S. Katz, G. Las, J. Alroy, M. Wu, B.F. Py, J. Yuan, J.T. Deeney, B.E. Corkey, O.S. Shirihai, Fission and selective fusion govern mitochondrial segregation and elimination by autophagy, EMBO J. 27 (2008) 433-446. (Pubitemid 351161653)
13. G. Twig, B. Hyde, O.S. Shirihai, Mitochondrial fusion, fission and autophagy as a quality control axis: the bioenergetic view, Biochim. Biophys. Acta 1777 (2008) 1092-1097.
14. N. Matsuda, S. Sato, K. Shiba, K. Okatsu, K. Saisho, C.A. Gautier, Y.S. Sou, S. Saiki, S. Kawajiri, F. Sato, M. Kimura, M. Komatsu, N. Hattori, K. Tanaka, PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy, J. Cell Biol. 189 (2010) 211-221.
15. S.M. Jin, M. Lazarou, C. Wang, L.A. Kane, D.P. Narendra, R.J. Youle, Mitochondrial membrane potential regulates PINK1 import and proteolytic destabilization by PARL, J. Cell Biol. 191 (2010) 933-942.
16. C. Meissner, H. Lorenz, A. Weihofen, D.J. Selkoe, M.K. Lemberg, The mitochondrial intramembrane protease PARL cleaves human Pink1 to regulate Pink1 trafficking, J. Neurochem. 117 (2011) 856-867.
17. G. Shi, J.R. Lee, D.A. Grimes, L. Racacho, D. Ye, H. Yang, O.A. Ross, M. Farrer, G.A. McQuibban, D.E. Bulman, Functional alteration of PARL contributes to mitochondrial dysregulation in Parkinson's disease, Hum. Mol. Genet. 20 (2011) 1966-1974.
18. A.W. Greene, K. Grenier, M.A. Aguileta, S. Muise, R. Farazifard, M.E. Haque, H.M. McBride, D.S. Park, E.A. Fon, Mitochondrial processing peptidase regulates PINK1 processing, import and Parkin recruitment, EMBO Rep. 13 (2012) 378-385.
19. B. Head, L. Griparic, M. Amiri, S. Gandre-Babbe, A.M. van der Bliek, Inducible proteolytic inactivation of OPA1 mediated by the OMA1 protease in mammalian cells, J. Cell Biol. 187 (2009) 959-966.
20. S. Ehses, I. Raschke, G. Mancuso, A. Bernacchia, S. Geimer, D. Tondera, J.C. Martinou, B. Westermann, E.I. Rugarli, T. Langer, Regulation of OPA1 processing and mitochondrial fusion by m-AAA protease isoenzymes and OMA1, J. Cell Biol. 187 (2009) 1023-1036.
21. M. Lazarou, S.M. Jin, L.A. Kane, R.J. Youle, Role of PINK1 binding to the TOM complex and alternate intracellular membranes in recruitment and activation of the E3 ligase Parkin, Dev. Cell 22 (2012) 320-333.
22. D.P. Narendra, S.M. Jin, A. Tanaka, D.F. Suen, C.A. Gautier, J. Shen, M.R. Cookson, R.J. Youle, PINK1 is selectively stabilized on impaired mitochondria to activate Parkin, PLoS Biol. 8 (2010) e1000298.
23. C. Vives-Bauza, C. Zhou, Y. Huang, M. Cui, R.L. de Vries, J. Kim, J. May, M.A. Tocilescu, W. Liu, H.S. Ko, J. Magrane, D.J. Moore, V.L. Dawson, R. Grailhe, T.M. Dawson, C. Li, K. Tieu, S. Przedborski, PINK1-dependent recruitment of Parkin to mitochondria in mitophagy, Proc. Natl. Acad. Sci. U. S. A. 107 (2010) 378-383.
24. K. Shiba-Fukushima, Y. Imai, S. Yoshida, Y. Ishihama, T. Kanao, S. Sato, N. Hattori, PINK1-mediated phosphorylation of the Parkin ubiquitin-like domain primes mitochondrial translocation of Parkin and regulates mitophagy, Sci. Rep. 2 (2012) 1002.
25. Y. Chen, G.W. Dorn 2nd, PINK1-phosphorylated mitofusin 2 is a Parkin receptor for culling damaged mitochondria, Science 340 (2013) 471-475.
26. X. Zheng, T. Hunter, Parkin mitochondrial translocation is achieved through a novel catalytic activity coupled mechanism, Cell Res. 23 (2013) 886-897.
27. S.A. Sarraf, M. Raman, V. Guarani-Pereira, M.E. Sowa, E.L. Huttlin, S.P. Gygi, J.W. Harper, Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization, Nature 496 (2013) 372-376.
28. S.R. Yoshii, C. Kishi, N. Ishihara, N. Mizushima, Parkin mediates proteasome-dependent protein degradation and rupture of the outer mitochondrial membrane, J. Biol. Chem. 286 (2011) 19630-19640.
29. L. Glauser, S. Sonnay, K. Stafa, D.J. Moore, Parkin promotes the ubiquitination and degradation of the mitochondrial fusion factor mitofusin 1, J. Neurochem. 118 (2011) 636-645.
30. A. Tanaka, M.M. Cleland, S. Xu, D.P. Narendra, D.F. Suen, M. Karbowski, R.J. Youle, Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin, J. Cell Biol. 191 (2010) 1367-1380.
31. M.E. Gegg, J.M. Cooper, K.Y. Chau, M. Rojo, A.H. Schapira, J.W. Taanman, Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy, Hum. Mol. Genet. 19 (2010) 4861-4870.
32. H. Wang, P. Song, L. Du, W. Tian, W. Yue, M. Liu, D. Li, B. Wang, Y. Zhu, C. Cao, J. Zhou, Q. Chen, Parkin ubiquitinates Drp1 for proteasome-dependent degradation: implication of dysregulated mitochondrial dynamics in Parkinson disease, J. Biol. Chem. 286 (2011) 11649-11658.
33. S. Geisler, K.M. Holmstrom, D. Skujat, F.C. Fiesel, O.C. Rothfuss, P.J. Kahle, W. Springer, PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1, Nat. Cell Biol. 12 (2010) 119-131.
34. S. Liu, T. Sawada, S. Lee, W. Yu, G. Silverio, P. Alapatt, I. Millan, A. Shen, W. Saxton, T. Kanao, R. Takahashi, N. Hattori, Y. Imai, B. Lu, Parkinson's disease-associated kinase PINK1 regulates Miro protein level and axonal transport of mitochondria, PLoS Genet. 8 (2012) e1002537.
35. J.Y. Lee, Y. Nagano, J.P. Taylor, K.L. Lim, T.P. Yao, Disease-causing mutations in Parkin impair mitochondrial ubiquitination, aggregation, and HDAC6-dependent mitophagy, J. Cell Biol. 189 (2010) 671-679.
36. N.C. Chan, A.M. Salazar, A.H. Pham, M.J. Sweredoski, N.J. Kolawa, R.L. Graham, S. Hess, D.C. Chan, Broad activation of the ubiquitin-proteasome system by Parkin is critical for mitophagy, Hum. Mol. Genet. 20 (2011) 1726-1737.
37. X. Wang, D. Winter, G. Ashra., J. Schlehe, Y.L. Wong, D. Selkoe, S. Rice, J. Steen, M.J. LaVoie, T.L. Schwarz, PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility, Cell 147 (2011) 893-906.
38. S. Xu, G. Peng, Y. Wang, S. Fang, M. Karbowski, The AAA-ATPase p97 is essential for outer mitochondrial membrane protein turnover, Mol. Biol. Cell 22 (2011) 291-300.
39. D. Narendra, L.A. Kane, D.N. Hauser, I.M. Fearnley, R.J. Youle, p62/SQSTM1 is required for Parkin-induced mitochondrial clustering but not mitophagy; VDAC1 is dispensable for both, Autophagy 6 (2010) 1090-1106.
40. K. Okatsu, K. Saisho, M. Shimanuki, K. Nakada, H. Shitara, Y.S. Sou, M. Kimura, S. Sato, N. Hattori, M. Komatsu, K. Tanaka, N. Matsuda, p62/SQSTM1 cooperates with Parkin for perinuclear clustering of depolarized mitochondria, Genes Cells 15 (2010) 887-900.
41. C. Van Humbeeck, T. Cornelissen, H. Hofkens, W. Mandemakers, K. Gevaert, B. De Strooper, W. Vandenberghe, Parkin interacts with Ambra1 to induce mitophagy, J. Neurosci. 31 (2011) 10249-10261.
42. N.C. Kim, E. Tresse, R.M. Kolaitis, A. Molliex, R.E. Thomas, N.H. Alami, B. Wang, A. Joshi, R.B. Smith, G.P. Ritson, B.J. Winborn, J. Moore, J.Y. Lee, T.P. Yao, L. Pallanck, M. Kundu, J.P. Taylor, VCP is essential for mitochondrial quality control by PINK1/Parkin and this function is impaired by VCP mutations, Neuron 78 (2013) 65-80.
43. J. Eschbach, J. Sinniger, J. Bouitbir, A. Fergani, A.I. Schlagowski, J. Zoll, B. Geny, F. Rene, Y. Larmet, V. Marion, R.H. Baloh, M.B. Harms, M.E. Shy, N. Messadeq, P. Weydt, J.P. Loeffler, A.C. Ludolph, L. Dupuis, Dynein mutations associated with hereditary motor neuropathies impair mitochondrial morphology and function with age, Neurobiol. Dis. 58C (2013) 220-230.
44. L. Liu, D. Feng, G. Chen, M. Chen, Q. Zheng, P. Song, Q. Ma, C. Zhu, R. Wang, W.Qi, L. Huang, P. Xue, B. Li, X. Wang, H. Jin, J. Wang, F. Yang, P. Liu, Y. Zhu, S. Sui, Q. Chen, Mitochondrial outer-membrane protein FUNDC1 mediates hypoxia-induced mitophagy in mammalian cells, Nat. Cell Biol. 14 (2012) 177-185.
45. P. Seibler, J. Graziotto, H. Jeong, F. Simunovic, C. Klein, D. Krainc, Mitochondrial Parkin recruitment is impaired in neurons derived from mutant PINK1 induced pluripotent stem cells, J. Neurosci. 31 (2011) 5970-5976.
46. E. Deas, H. Plun-Favreau, S. Gandhi, H. Desmond, S. Kjaer, S.H. Loh, A.E. Renton, R.J. Harvey, A.J. Whitworth, L.M. Martins, A.Y. Abramov, N.W. Wood, PINK1 cleavage at position A103 by the mitochondrial protease PARL, Hum. Mol. Genet. 20 (2011) 867-879.
47. S. Gispert, F. Ricciardi, A. Kurz, M. Azizov, H.H. Hoepken, D. Becker, W. Voos, K. Leuner, W.E. Muller, A.P. Kudin, W.S. Kunz, A. Zimmermann, J. Roeper, D. Wenzel, M. Jendrach, M. Garcia-Arencibia, J. Fernandez-Ruiz, L. Huber, H. Rohrer, M. Barrera, A.S. Reichert, U. Rub, A. Chen, R.L. Nussbaum, G. Auburger, Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration, PLoS One 4 (2009) e5777.
48. A. Grunewald, L. Voges, A. Rakovic, M. Kasten, H. Vandebona, C. Hemmelmann, K. Lohmann, S. Orolicki, A. Ramirez, A.H. Schapira, P.P. Pramstaller, C.M. Sue, C. Klein, Mutant Parkin impairs mitochondrial function and morphology in human fibroblasts, PLoS One 5 (2010) e12962.
49. A. Rakovic, A. Grunewald, P. Seibler, A. Ramirez, N. Kock, S. Orolicki, K. Lohmann, C. Klein, Effect of endogenous mutant and wild-type PINK1 on Parkin in fibroblasts from Parkinson disease patients, Hum. Mol. Genet. 19 (2010) 3124-3137.
50. A. Rakovic, A. Grunewald, J. Kottwitz, N. Bruggemann, P.P. Pramstaller, K. Lohmann, C. Klein, Mutations in PINK1 and Parkin impair ubiquitination of Mitofusins in human fibroblasts, PLoS One 6 (2011) e16746.
51. R.H. Baloh, R.E. Schmidt, A. Pestronk, J. Milbrandt, Altered axonal mitochondrial transport in the pathogenesis of Charcot-Marie-Tooth disease from mitofusin 2 mutations, J. Neurosci. 27 (2007) 422-430. (Pubitemid 46106016)
52. A.L. Misko, Y. Sasaki, E. Tuck, J. Milbrandt, R.H. Baloh, Mitofusin2 mutations disrupt axonal mitochondrial positioning and promote axon degeneration, J. Neurosci. 32 (2012) 4145-4155.
53. C. Manzoni, P.A. Lewis, Dysfunction of the autophagy/lysosomal degradation pathway is a shared feature of the genetic synucleinopathies, FASEB J. (2013).
54. K. Vekrellis, M. Xilouri, E. Emmanouilidou, H.J. Rideout, L. Stefanis, Pathological roles of alpha-synuclein in neurological disorders, Lancet Neurol. 10 (2011) 1015-1025.
55. A.R. Winslow, D.C. Rubinsztein, The Parkinson disease protein alpha-synuclein inhibits autophagy, Autophagy 7 (2011) 429-431.
56. S. Chen, X. Zhang, L. Song, W. Le, Autophagy dysregulation in amyotrophic lateral sclerosis, Brain Pathol. 22 (2012) 110-116.
57. G. Dobrowolny, M. Aucello, E. Rizzuto, S. Beccafico, C. Mammucari, S. Bonconpagni, S. Belia, F. Wannenes, C. Nicoletti, Z. Del Prete, N. Rosenthal, M. Molinaro, F. Protasi, G. Fano, M. Sandri, A. Musaro, Skeletal muscle is a primary target of SOD1G93A-mediated toxicity, Cell Metab. 8 (2008) 425-436.
58. M.P. Ordonez, E.A. Roberts, C.U. Kidwell, S.H. Yuan, W.C. Plaisted, L.S. Goldstein, Disruption and therapeutic rescue of autophagy in a human neuronal model of Niemann Pick type C1, Hum. Mol. Genet. 21 (2012) 2651-2662.
59. R. de Pablo-Latorre, A. Saide, E.V. Polishhuck, E. Nusco, A. Fraldi, A. Ballabio, Impaired parkin-mediated mitochondrial targeting to autophagosomes differentially contributes to tissue pathology in lysosomal storage diseases, Hum. Mol. Genet. 21 (2012) 1770-1781.
60. A. Ferri, P. Fiorenzo, M. Nencini, M. Cozzolino, M.G. Pesaresi, C. Valle, S. Sepe, S. Moreno, M.T. Carri, Glutaredoxin 2 prevents aggregation of mutant SOD1 in mitochondria and abolishes its toxicity, Hum. Mol. Genet. 19 (2010) 4529-4542.
61. W. Liu, F. Tian, N. Morimoto, T. Yamashita, Y. Ikeda, K. Deguchi, K. Abe, Dynamic changes of mitochondrial fusion and fission proteins in a murine model of amyotrophic lateral sclerosis, Curr. Neurovasc. Res. (2013).
62. A. Grunewald, B. Arns, P. Seibler, A. Rakovic, A. Munchau, A. Ramirez, C.M. Sue, C. Klein, ATP13A2 mutations impair mitochondrial function in fibroblasts from patients with Kufor-Rakeb syndrome, Neurobiol. Aging 33 (2012) 1843 e1841-e1847.
63. H. Gao, W. Yang, Z. Qi, L. Lu, C. Duan, C. Zhao, H. Yang, DJ-1 protects dopaminergic neurons against rotenone-induced apoptosis by enhancing ERK-dependent mitophagy, J. Mol. Biol. 423 (2012) 232-248.
64. G. Krebiehl, S. Ruckerbauer, L.F. Burbulla, N. Kieper, B. Maurer, J. Waak, H. Wolburg, Z. Gizatullina, F.N. Gellerich, D. Woitalla, O. Riess, P.J. Kahle, T. Proikas-Cezanne, R. Kruger, Reduced basal autophagy and impaired mitochondrial dynamics due to loss of Parkinson's disease-associated protein DJ-1, PLoS One 5 (2010) e9367.
65. A.P. Joselin, S.J. Hewitt, S.M. Callaghan, R.H. Kim, Y.H. Chung, T.W. Mak, J. Shen, R.S. Slack, D.S. Park, ROS-dependent regulation of Parkin and DJ-1 localization during oxidative stress in neurons, Hum. Mol. Genet. 21 (2012) 4888-4903.
66. C. Lagier-Tourenne, M. Polymenidou, K.R. Hutt, A.Q. Vu, M. Baughn, S.C. Huelga, K.M. Clutario, S.C. Ling, T.Y. Liang, C. Mazur, E. Wancewicz, A.S. Kim, A. Watt, S. Freier, G.G. Hicks, J.P. Donohue, L. Shiue, C.F. Bennett, J. Ravits, D.W. Cleveland, G.W. Yeo, Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs, Nat. Neurosci. 15 (2012) 1488-1497.
67. B. Heeman, C. Van den Haute, S.A. Aelvoet, F. Valsecchi, R.J. Rodenburg, V. Reumers, Z. Debyser, G. Callewaert, W.J. Koopman, P.H. Willems, V. Baekelandt, Depletion of PINK1 affects mitochondrial metabolism, calcium homeostasis and energy maintenance, J. Cell Sci. 124 (2011) 1115-1125.
68. T. Cui, C. Fan, L. Gu, H. Gao, Q. Liu, T. Zhang, Z. Qi, C. Zhao, H. Zhao, Q. Cai, H. Yang, Silencing of PINK1 induces mitophagy via mitochondrial permeability transition in dopaminergic MN9D cells, Brain Res. 1394 (2011) 1-13.
69. R.K. Dagda, S.J. Cherra 3rd, S.M. Kulich, A. Tandon, D. Park, C.T. Chu, Loss of PINK1 function promotes mitophagy through effects on oxidative stress and mitochondrial fission, J. Biol. Chem. 284 (2009) 13843-13855.
70. E.S. Vincow, G. Merrihew, R.E. Thomas, N.J. Shulman, R.P. Beyer, M.J. MacCoss, L.J. Pallanck, The PINK1-Parkin pathway promotes both mitophagy and selective respiratory chain turnover in vivo, Proc. Natl. Acad. Sci. U. S. A. 110 (2013) 6400-6405.
71. A. Rana, M. Rera, D.W. Walker, Parkin overexpression during aging reduces proteotoxicity, alters mitochondrial dynamics, and extends lifespan, Proc. Natl. Acad. Sci. U. S. A. 110 (2013) 8638-8643.
72. L. Dupuis, A. Fergani, K.E. Braunstein, J. Eschbach, N. Holl, F. Rene, J.L. Gonzalez De Aguilar, B. Zoerner, B. Schwalenstocker, A.C. Ludolph, J.P. Loeffler, Mice with a mutation in the dynein heavy chain 1 gene display sensory neuropathy but lack motor neuron disease, Exp. Neurol. 215 (2009) 146-152.
73. K.E. Braunstein, J. Eschbach, K. Rona-Voros, R. Soylu, E. Mikrouli, Y. Larmet, F. Rene, J.L. De Aguilar, J.P. Loeffler, H.P. Muller, S. Bucher, T. Kaulisch, H.G. Niessen, J. Tillmanns, K. Fischer, B. Schwalenstocker, J. Kassubek, B. Pichler, D. Stiller, A. Petersen, A.C. Ludolph, L. Dupuis, A point mutation in the dynein heavy chain gene leads to striatal atrophy and compromises neurite outgrowth of striatal neurons, Hum. Mol. Genet. 19 (2010) 4385-4398.
74. R. Von Coelln, B. Thomas, J.M. Savitt, K.L. Lim, M. Sasaki, E.J. Hess, V.L. Dawson, T.M. Dawson, Loss of locus coeruleus neurons and reduced startle in parkin null mice, Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 10744-10749. (Pubitemid 38955813)
75. A. Siddiqui, I. Hanson, J.K. Andersen, Mao-B elevation decreases parkin's ability to efficiently clear damaged mitochondria: protective effects of rapamycin, Free Radic. Res. 46 (2012) 1011-1018.
76. Q. Cai, H.M. Zakaria, A. Simone, Z.H. Sheng, Spatial parkin translocation and degradation of damaged mitochondria via mitophagy in live cortical neurons, Curr. Biol. 22 (2012) 545-552.
77. H. Meyer, M. Bug, S. Bremer, Emerging functions of the VCP/p97 AAA-ATPase in the ubiquitin system, Nat. Cell Biol. 14 (2012) 117-123.
78. I.H. Henn, L. Bouman, J.S. Schlehe, A. Schlierf, J.E. Schramm, E. Wegener, K. Nakaso, C. Culmsee, B. Berninger, D. Krappmann, J. Tatzelt, K.F. Winklhofer, Parkin mediates neuroprotection through activation of IkappaB kinase/nuclear factor-kappaB signaling, J. Neurosci. 27 (2007) 1868-1878.
79. A.K. Muller-Rischart, A. Pilsl, P. Beaudette, M. Patra, K. Hadian, M. Funke, R. Peis, A. Deinlein, C. Schweimer, P.H. Kuhn, S.F. Lichtenthaler, E. Motori, S. Hrelia, W. Wurst, D. Trumbach, T. Langer, D. Krappmann, G. Dittmar, J. Tatzelt, K.F. Winklhofer, The E3 ligase parkin maintains mitochondrial integrity by increasing linear ubiquitination of NEMO, Mol. Cell 49 (2013) 908-921.
80. K.Y. Kim, M.V. Stevens, M.H. Akter, S.E. Rusk, R.J. Huang, A. Cohen, A. Noguchi, D. Springer, A.V. Bocharov, T.L. Eggerman, D.F. Suen, R.J. Youle, M. Amar, A.T. Remaley, M.N. Sack, Parkin is a lipid-responsive regulator of fat uptake in mice and mutant human cells, J. Clin. Invest. 121 (2011) 3701-3712.
81. S. Michiorri, V. Gelmetti, E. Giarda, F. Lombardi, F. Romano, R. Marongiu, S. Nerini-Molteni, P. Sale, R. Vago, G. Arena, L. Torosantucci, L. Cassina, M.A. Russo, B. Dallapiccola, E.M. Valente, G. Casari, The Parkinson-associated protein PINK1 interacts with Beclin1 and promotes autophagy, Cell Death Differ. 17 (2010) 962-974.
82. G. Arena, V. Gelmetti, L. Torosantucci, D. Vignone, G. Lamorte, P. De Rosa, E. Cilia, E.A. Jonas, E.M. Valente, PINK1 protects against cell death induced by mitochondrial depolarization, by phosphorylating Bcl-xL and impairing its pro-apoptotic cleavage, Cell Death Differ. 20 (2013) 920-930.
83. P. Amati-Bonneau, M.L. Valentino, P. Reynier, M.E. Gallardo, B. Bornstein, A. Boissiere, Y. Campos, H. Rivera, J.G. de la Aleja, R. Carroccia, L. Iommarini, P. Labauge, D. Figarella-Branger, P. Marcorelles, A. Furby, K. Beauvais, F. Letournel, R. Liguori, C. La Morgia, P. Montagna, M. Liguori, C. Zanna, M. Rugolo, A. Cossarizza, B. Wissinger, C. Verny, R. Schwarzenbacher, M.A. Martin, J. Arenas, C. Ayuso, R. Garesse, G. Lenaers, D. Bonneau, V. Carelli, OPA1 mutations induce mitochondrial DNA instability and optic atrophy 'plus' phenotypes, Brain 131 (2008) 338-351. (Pubitemid 351197609)
84. G. Hudson, P. Amati-Bonneau, E.L. Blakely, J.D. Stewart, L. He, A.M. Schaefer, P.G. Griffiths, K. Ahlqvist, A. Suomalainen, P. Reynier, R. McFarland, D.M. Turnbull, P.F. Chinnery, R.W. Taylor, Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance, Brain 131 (2008) 329-337. (Pubitemid 351197604)
85. C. Rouzier, S. Bannwarth, A. Chaussenot, A. Chevrollier, A. Verschueren, N. Bonello-Palot, K. Fragaki, A. Cano, J. Pouget, J.F. Pellissier, V. Procaccio, B. Chabrol, V. Paquis-Flucklinger, The MFN2 gene is responsible for mitochondrial DNA instability and optic atrophy 'plus' phenotype, Brain 135 (2012) 23-34.
86. C. Munch, R. Sedlmeier, T. Meyer, V. Homberg, A.D. Sperfeld, A. Kurt, J. Prudlo, G. Peraus, C.O. Hanemann, G. Stumm, A.C. Ludolph, Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS, Neurology 63 (2004) 724-726. (Pubitemid 39100836)
87. I. Puls, S.J. Oh, C.J. Sumner, K.E. Wallace, M.K. Floeter, E.A. Mann, W.R. Kennedy, G. Wendelschafer-Crabb, A. Vortmeyer, R. Powers, K. Finnegan, E.L. Holzbaur, K.H. Fischbeck, C.L. Ludlow, Distal spinal and bulbar muscular atrophy caused by dynactin mutation, Ann. Neurol. 57 (2005) 687-694. (Pubitemid 40628857)
88. M.J. Farrer, M.M. Hulihan, J.M. Kachergus, J.C. Dachsel, A.J. Stoessl, L.L. Grantier, S. Calne, D.B. Calne, B. Lechevalier, F. Chapon, Y. Tsuboi, T. Yamada, L. Gutmann, B. Elibol, K.P. Bhatia, C. Wider, C. Vilarino-Guell, O.A. Ross, L.A. Brown, M. Castanedes-Casey, D.W. Dickson, Z.K. Wszolek, DCTN1 mutations in Perry syndrome, Nat. Genet. 41 (2009) 163-165.
89. H. Harris, D.C. Rubinsztein, Control of autophagy as a therapy for neurode-generative disease, Nat. Rev. Neurol. 8 (2012) 108-117.
90. D.C. Rubinsztein, P. Codogno, B. Levine, Autophagy modulation as a potential therapeutic target for diverse diseases, Nat. Rev. Drug Discov. 11 (2012) 709-730.
91. I.F. Wang, B.S. Guo, Y.C. Liu, C.C. Wu, C.H. Yang, K.J. Tsai, C.K. Shen, Autophagy activators rescue and alleviate pathogenesis of a mouse model with proteinopathies of the TAR DNA-binding protein 43, Proc. Natl. Acad. Sci. U. S. A. 109 (2012) 15024-15029.
92. I.F. Wang, K.J. Tsai, C.K. Shen, Autophagy activation ameliorates neuronal pathogenesis of FTLD-U mice: a new light for treatment of TARDBP/TDP-43 proteinopathies, Autophagy 9 (2013) 239-240.
93. J.K. Ching, C.C. Weihl, Rapamycin-induced autophagy aggravates pathology and weakness in a mouse model of VCP-associated myopathy, Autophagy 9 (2013) 799-800.
94. X. Zhang, L. Li, S. Chen, D. Yang, Y. Wang, Z. Wang, W. Le, Rapamycin treatment augments motor neuron degeneration in SOD1(G93A) mouse model of amyotrophic lateral sclerosis, Autophagy 7 (2011) 412-425.
95. Y. Tashiro, M. Urushitani, H. Inoue, M. Koike, Y. Uchiyama, M. Komatsu, K. Tanaka, M. Yamazaki, M. Abe, H. Misawa, K. Sakimura, H. Ito, R. Takahashi, Motor neuron-specific disruption of proteasomes, but not autophagy, replicates amyotrophic lateral sclerosis, J. Biol. Chem. 287 (2012) 42984-42994.
96. P. Grumati, L. Coletto, P. Sabatelli, M. Cescon, A. Angelin, E. Bertaggia, B. Blaauw, A. Urciuolo, T. Tiepolo, L. Merlini, N.M. Maraldi, P. Bernardi, M. Sandri, P. Bonaldo, Autophagy is defective in collagen VI muscular dystrophies, and its reactivation rescues myofiber degeneration, Nat. Med. 16 (2010) 1313-1320.
97. K. Rona-Voros, P. Weydt, The role of PGC-1alpha in the pathogenesis of neurodegenerative disorders, Curr. Drug Targets 11 (2010) 1262-1269.
98. T. Tsunemi, T.D. Ashe, B.E. Morrison, K.R. Soriano, J. Au, R.A. Roque, E.R. Lazarowski, V.A. Damian, E. Masliah, A.R. La Spada, PGC-1alpha rescues Huntington's disease proteotoxicity by preventing oxidative stress and promoting TFEB function, Sci. Transl. Med. 4 (2012) 142-197.
99. S. Da Cruz, P.A. Parone, V.S. Lopes, C. Lillo, M. McAlonis-Downes, S.K. Lee, A.P. Vetto, S. Petrosyan, M. Marsala, A.N. Murphy, D.S. Williams, B.M. Spiegelman, D.W. Cleveland, Elevated PGC-1alpha activity sustains mitochondrial biogenesis and muscle function without extending survival in a mouse model of inherited ALS, Cell Metab. 15 (2012) 778-786.
100. N.T. Hertz, A. Berthet, M.L. Sos, K.S. Thorn, A.L. Burlingame, K. Nakamura, K.M. Shokat, A neo-substrate that amplifies catalytic activity of Parkinson's-disease-relatedkinase PINK1, Cell 154 (4) (2013 Aug 15) 737-747.